Antipsychotic Drugs Linked to Heart Attacks: Risks Doubled
A recent study has found that heart attack risks were doubled in patients who were taking widely-used antipsychotic drugs. These newer medicines are no safer for users than the older medications that they have largely replaced. The risk of heart attack for people who were taking the newer drugs—including Eli Lilly & Company’s Zyprexa and Johnson & Johnson’s Risperdal—rose according to their dosage, according to a study published in the New England Journal of Medicine.
These medications were introduced to the market 15 years ago as safer, more gentle alternatives to the older schizophrenia drugs, which were widely known to raise health risks. These newer drugs first became available in the mid-1990’s during a time of concern about the neurological disorders caused by older medications, such as Thorazine and Haldol. These older drugs made users drool, doze and twitch, which made them undesirable both for the patients and their families. However, a series of studies in the past several years have since undermined the initial claims that newer antipsychotic drugs were safer and more effective than the older ones. If you have questions about how antipsychotic drugs have affected you or a loved one, and are interested in exploring your legal options, contact the attorneys at The Cartwright Law Firm.